MCCULLOCH KEVIN (See Remarks) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/15/2025ACC: 0002031695-25-000004
Officer· See Remarks
Since Mar 2026
-2K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−2K
Price / share
—
Trade value
—
% of position
New position
9/11/2025
2K→0.00
Total
Net shares
−2K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/11/2025 | J · J | −2K | — | — | New position | 2K | 0.00 |
| Total | −2K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned25K
Common Stock
DirectShares owned1.70M
Total
1.70M direct·25K indirect1.73M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Common Stock | 1.70M | Direct |
| Total | 1.73M | 1.70M direct·25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported